Cargando…
Bifidobacterium longum and Galactooligosaccharide Improve Skin Barrier Dysfunction and Atopic Dermatitis-like Skin
PURPOSE: The beneficial effects of a combination therapy using Bifidobacterium longum and galactooligosaccharide (GOS) for the treatment of atopic dermatitis (AD) have not been elucidated. METHODS: Gene expressions of interleukin (IL)-4 and IL-13 from peripheral blood mononuclear cells and fecal abu...
Autores principales: | Kim, Sukyung, Han, Song-Yi, Lee, Jinyoung, Kim, Na-Rae, Lee, Bo Ra, Kim, Hyunmi, Kwon, Mijeoung, Ahn, Kangmo, Noh, Youngbae, Kim, Sang Jong, Lee, Phyrim, Kim, Dongki, Kim, Byung Eui, Kim, Jihyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523416/ https://www.ncbi.nlm.nih.gov/pubmed/36174995 http://dx.doi.org/10.4168/aair.2022.14.5.549 |
Ejemplares similares
-
Alterations of Epidermal Lipid Profiles and Skin Microbiome in Children With Atopic Dermatitis
por: Kim, Jihyun, et al.
Publicado: (2023) -
Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
por: Fang, Zhifeng, et al.
Publicado: (2022) -
Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI
por: Kim, Min Jeong, et al.
Publicado: (2018) -
Particulate matter causes skin barrier dysfunction
por: Kim, Byung Eui, et al.
Publicado: (2021) -
Inhibitory Effect of Galactooligosaccharide on Skin Pigmentation
por: Suh, Min Geun, et al.
Publicado: (2019)